The impact of gender and anchor drugs on TDF renal toxicity

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e11-2. doi: 10.1097/QAI.0b013e3181ef7930.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Anti-HIV Agents / adverse effects*
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Dideoxynucleosides / administration & dosage
  • Dideoxynucleosides / therapeutic use
  • Emtricitabine
  • Female
  • Glomerular Filtration Rate / drug effects
  • HIV Infections / drug therapy*
  • Humans
  • Kidney / drug effects*
  • Lamivudine / administration & dosage
  • Lamivudine / therapeutic use
  • Male
  • Organophosphonates / administration & dosage
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Sex Factors
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Organophosphonates
  • Deoxycytidine
  • Lamivudine
  • Tenofovir
  • Emtricitabine
  • Adenine
  • abacavir